A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases
Conclusion: Statins’ adverse reactions differ across populations. For those with hypercholesterolemia and diabetes, statins’ impact on transaminase levels is similar. Yet patients with coronary heart disease, acute coronary syndrome, or acute stroke show varying responses. Notably, myalgia risk in h...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/cdr/6684099 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689558580461568 |
|---|---|
| author | Wanying Li Ding Wang Caiyue Lin Tongze Cai Mei Zhao Liuguan Liang Xingxing Zhao Xin He Xiaoyue Liang Jinghui Zheng |
| author_facet | Wanying Li Ding Wang Caiyue Lin Tongze Cai Mei Zhao Liuguan Liang Xingxing Zhao Xin He Xiaoyue Liang Jinghui Zheng |
| author_sort | Wanying Li |
| collection | DOAJ |
| description | Conclusion: Statins’ adverse reactions differ across populations. For those with hypercholesterolemia and diabetes, statins’ impact on transaminase levels is similar. Yet patients with coronary heart disease, acute coronary syndrome, or acute stroke show varying responses. Notably, myalgia risk in hypercholesterolemia and coronary disease patients using different statins is comparable, but those with acute coronary syndrome or stroke, especially on high-dose rosuvastatin, have a higher myalgia risk. |
| format | Article |
| id | doaj-art-b81f0c937ee149bcbf3bfa697f5fde32 |
| institution | DOAJ |
| issn | 1755-5922 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiovascular Therapeutics |
| spelling | doaj-art-b81f0c937ee149bcbf3bfa697f5fde322025-08-20T03:21:34ZengWileyCardiovascular Therapeutics1755-59222025-01-01202510.1155/cdr/6684099A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various DiseasesWanying Li0Ding Wang1Caiyue Lin2Tongze Cai3Mei Zhao4Liuguan Liang5Xingxing Zhao6Xin He7Xiaoyue Liang8Jinghui Zheng9Graduate SchoolDepartment of CardiologyGraduate SchoolDepartment of OncologyDepartment of Pulmonary and Critical Care MedicineGraduate SchoolGraduate SchoolDepartment of CardiologyDepartment of CardiologyAcademic Affairs OfficeConclusion: Statins’ adverse reactions differ across populations. For those with hypercholesterolemia and diabetes, statins’ impact on transaminase levels is similar. Yet patients with coronary heart disease, acute coronary syndrome, or acute stroke show varying responses. Notably, myalgia risk in hypercholesterolemia and coronary disease patients using different statins is comparable, but those with acute coronary syndrome or stroke, especially on high-dose rosuvastatin, have a higher myalgia risk.http://dx.doi.org/10.1155/cdr/6684099 |
| spellingShingle | Wanying Li Ding Wang Caiyue Lin Tongze Cai Mei Zhao Liuguan Liang Xingxing Zhao Xin He Xiaoyue Liang Jinghui Zheng A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases Cardiovascular Therapeutics |
| title | A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases |
| title_full | A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases |
| title_fullStr | A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases |
| title_full_unstemmed | A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases |
| title_short | A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases |
| title_sort | meta analysis of the incidence of adverse reactions of statins in various diseases |
| url | http://dx.doi.org/10.1155/cdr/6684099 |
| work_keys_str_mv | AT wanyingli ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT dingwang ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT caiyuelin ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT tongzecai ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT meizhao ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT liuguanliang ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT xingxingzhao ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT xinhe ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT xiaoyueliang ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT jinghuizheng ametaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT wanyingli metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT dingwang metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT caiyuelin metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT tongzecai metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT meizhao metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT liuguanliang metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT xingxingzhao metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT xinhe metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT xiaoyueliang metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases AT jinghuizheng metaanalysisoftheincidenceofadversereactionsofstatinsinvariousdiseases |